反応式
[CH3:1][N:2]1[C:7](=[O:8])[C:6]2[C:9]([C:13]([O:15][CH3:16])=[O:14])=[C:10]([CH3:12])[S:11][C:5]=2[N:4]([CH2:17][CH:18]([CH3:20])[CH3:19])[C:3]1=[O:21].BrN1C(=O)CCC1=O.C(=O)(O)[O-].[Na+].[CH3:35][C:36]1[NH:37][C:38]2[C:43]([CH:44]=1)=[CH:42][CH:41]=[CH:40][CH:39]=2>C(Cl)(Cl)Cl>[CH3:1][N:2]1[C:7](=[O:8])[C:6]2[C:9]([C:13]([O:15][CH3:16])=[O:14])=[C:10]([CH2:12][C:44]3[C:43]4[C:38](=[CH:39][CH:40]=[CH:41][CH:42]=4)[NH:37][C:36]=3[CH3:35])[S:11][C:5]=2[N:4]([CH2:17][CH:18]([CH3:19])[CH3:20])[C:3]1=[O:21]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of methyl 1,2,3,4-tetrahydro-3,6-dimethyl-1-(2-methylpropyl)-2,4-dioxo-thieno[2,3-d]pyrimidine-5-carboxylate [example 1 step a), 7.00 g) and N-bromosuccinimide (4.42 g) in chloroform (140 ml) was refluxed under illumination from a tungsten lamp for 2 hours. The solution was cooled to room temperature, saturated aqueous sodium bicarbonate solution (140 ml) and 2-methylindole (5.92 g) were added and the mixture stirred rapidly for 48 hours. The phases were separated and the aqueous phase extracted with dichloromethane (100 ml). Combined organic extracts were dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The residue was purified by column chromatography over silica, eluting with ethyl acetate/i-hexane (1:3) to give the sub-title compound as a pale brown solid (6.68 g).
後処理
- customThe phases were separated
- extractionthe aqueous phase extracted with dichloromethane (100 ml)
- dry with materialCombined organic extracts were dried over anhydrous magnesium sulfate
- filtrationfiltered
- customevaporated under reduced pressure
- customThe residue was purified by column chromatography over silica
- washeluting with ethyl acetate/i-hexane (1:3)
出典と根拠
- ORDレコード
- ord-91d157422d4442b1855567827be78702
- 出典データセット
- uspto-grants-2008_04
- 特許番号
- US07361660B2
関連ノート
読み込み中…